The aim of the present study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.
Principal Investigator(s)
Email for information
Research Start Date
Status
Active
The aim of the present study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.